S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30

Roivant Sciences Stock Forecast, Price & News

+0.03 (+0.41%)
(As of 01/24/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
369,300 shs
Average Volume
334,753 shs
Market Capitalization
$4.99 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive ROIV News and Ratings via Email

Sign-up to receive the latest news and ratings for Roivant Sciences and its competitors with MarketBeat's FREE daily newsletter.

Roivant Sciences logo

About Roivant Sciences

Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.


See More Headlines

Industry, Sector and Symbol

Current Symbol
Year Founded

Sales & Book Value

Annual Sales


Pretax Margin




Free Float
Market Cap
$4.99 billion
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End


Overall MarketRank

1.70 out of 5 stars

Medical Sector

732nd out of 1,415 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Roivant Sciences (NASDAQ:ROIV) Frequently Asked Questions

Is Roivant Sciences a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roivant Sciences in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Roivant Sciences stock.
View analyst ratings for Roivant Sciences
or view top-rated stocks.

How were Roivant Sciences' earnings last quarter?

Roivant Sciences Ltd (NASDAQ:ROIV) announced its earnings results on Monday, November, 15th. The company reported ($0.87) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.06) by $0.19. The business earned $13.99 million during the quarter, compared to analysts' expectations of $5.30 million.
View Roivant Sciences' earnings history

What price target have analysts set for ROIV?

7 Wall Street analysts have issued 12-month price objectives for Roivant Sciences' shares. Their forecasts range from $10.00 to $15.00. On average, they expect Roivant Sciences' share price to reach $12.67 in the next twelve months. This suggests a possible upside of 74.0% from the stock's current price.
View analysts' price targets for Roivant Sciences
or view top-rated stocks among Wall Street analysts.

What is Roivant Sciences' stock symbol?

Roivant Sciences trades on the NASDAQ under the ticker symbol "ROIV."

How do I buy shares of Roivant Sciences?

Shares of ROIV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Roivant Sciences' stock price today?

One share of ROIV stock can currently be purchased for approximately $7.28.

How much money does Roivant Sciences make?

Roivant Sciences has a market capitalization of $4.99 billion.

How many employees does Roivant Sciences have?

Roivant Sciences employs 2,021 workers across the globe.

What is Roivant Sciences' official website?

The official website for Roivant Sciences is roivant.com.

Where are Roivant Sciences' headquarters?

Roivant Sciences is headquartered at Clarendon House, 2 Church Street, Hamilton Parish HM 11.

This page was last updated on 1/25/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.